A candling assembly for use within an ear canal of a person undergoing an ear candling process. The candling assembly includes an ear candle and a disk. The ear candle extends along a shaft between a first end and a second end. The disk is secured to the shaft, and the disk is movable between a closed position and an open position. The disk defines a pocket that opens toward the second end, when the disk is in the open position, configured to collect debris falling from the second end toward the ear canal of the ear and the user of the candling assembly. The disk is collapsed onto itself, with a portion of the shaft of the ear candle therebetween, when the disk is in the closed position. As such, the ear candling assembly is configured to be packaged for storage in a bag when not in use.

An eardrum incision device includes a main body, a replaceable inserting portion and a display device. The replaceable inserting portion is detachably connected to the main body. The replaceable inserting portion has an insertion end located on a side far away from the main body and adapted to be inserted into an ear canal of a user. The replaceable inserting portion includes an image-capturing device, a mounting hole and a replaceable incision component. The image-capturing device is disposed at the insertion end. The mounting hole extends in a direction from the insertion end toward the main body. The replaceable incision component is removably disposed in the mounting hole and adapted to pierce out of the mounting hole in a direction toward the insertion end, so as to incise the eardrum of the user. The display device is disposed on the main body and electrically connected to the image-capturing device.

The present disclosure provides a device (30) for delivering a substance to the inner ear. The device (30) comprises a pressure oscillator (32) configured to generate pressurised air at a predetermined oscillation frequency, an aural probe (31) comprising an air passageway extending from a first end of the aural probe (31) to a second end of the aural probe (31), the first end being the end to be inserted into the ear canal, a tube (33) arranged to couple the second end of the aural probe (31) to the pressure oscillator (32), and a pressure relief valve (34) disposed at the tube (33) and/or the aural probe (31) configured to release a portion or the generated pressurised air from within the tube (33) and/or the aural probe (31) when a pressure within the tube (33) and/or the aural probe (31) reaches a predetermined maximum pressure. The present disclosure further provides a method for delivering a substance to the inner ear, the method comprising the steps of: (i) administering the substance to the middle ear; and (ii) generating oscillating air pressure within the ear canal.

The present disclosure provides a device (30) for delivering a substance to the inner ear. The device (30) comprises a pressure oscillator (32) configured to generate pressurised air at a predetermined oscillation frequency, an aural probe (31) comprising an air passageway extending from a first end of the aural probe (31) to a second end of the aural probe (31), the first end being the end to be inserted into the ear canal, a tube (33) arranged to couple the second end of the aural probe (31) to the pressure oscillator (32), and a pressure relief valve (34) disposed at the tube (33) and/or the aural probe (31) configured to release a portion or the generated pressurised air from within the tube (33) and/or the aural probe (31) when a pressure within the tube (33) and/or the aural probe (31) reaches a predetermined maximum pressure. The present disclosure further provides a method for delivering a substance to the inner ear, the method comprising the steps of: (i) administering the substance to the middle ear; and (ii) generating oscillating air pressure within the ear canal.

A method and system of treating connective tissue to increase flexibility of the connective tissue or decrease tension in the connective tissue includes forming perforations in the connective tissue to at least 90% of the depth or thickness of the connective tissue and maintaining the perforations in the connective tissue. The method alters the tissue to enhance the fundamental mechanisms involved the immunology, biochemistry, and molecular genetics of the metabolism of the connective tissue.

Systems, methods and devices for paired training include timing controls so that training and neural stimulation can be provided simultaneously. Paired trainings may include therapies, rehabilitation and performance enhancement training. Stimulations of nerves such as the vagus nerve that affect subcortical regions such as the nucleus basalis, locus coeruleus or amygdala induce plasticity in the brain, enhancing the effects of a variety of therapies, such as those used to treat tinnitus, stroke, traumatic brain injury and post-traumatic stress disorder.

A utility device is provided for insertion into an ear. The utility device comprises a first tip portion. The first tip portion can include a first end, a base, a plurality of first ridges extending between the first end and the base, and a plurality of second ridges extending between each of the plurality of first ridges. The utility device can include an intermediate region and a central portion. The intermediate portion can connect the central portion to the first tip portion. The central portion can allow a user to grip and/or hold the utility device.

An active noise reduction system using adaptive filters. A method of operation the active noise reduction system includes smoothing a stream of leakage factors. The frequency of a noise reduction signal may be related to the engine speed of an engine associated with the system within which the active noise reduction system is operated. The engine speed signal may be a high latency signal and may be obtained by the active noise reduction system over audio entertainment circuitry.

Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.

Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.